Stay updated on Timing of Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the Timing of Pembrolizumab in NSCLC Clinical Trial page
- Check4 days agoChange DetectedCore study record details for Contacts/Locations and Study Status were added to the history, along with an item labeled 690, and the entry from 2026-07-02 was deleted.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, representing a deployment-level update to the record history interface. This change does not modify study data, content, or user-facing functionality.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedA new study record version (689, dated 2026-07-02) was added, updating the Study Status and the Contacts/Locations sections and referencing Revision: v3.6.3; the prior version on 2026-06-17 (Revision: v3.6.2) was removed.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision: v3.6.2 was added to the history and Revision: v3.6.0 was removed.SummaryDifference0.0%

- Check48 days agoChange DetectedVersion 686 and 687 were added to the study history on 2026-06-12 and 2026-06-17, updating the Study Status and Contacts/Locations; the 2026-05-29 entry was deleted.SummaryDifference0.1%

- Check55 days agoChange DetectedNew entry states No longer looking for participants and the record shows Revision: v3.6.0. The prior Revision: v3.5.5 entry was removed.SummaryDifference0.0%

Stay in the know with updates to Timing of Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.